BVXV News and Press, BiondVax Pharmaceuticals Ltd. From 05/12/22

BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program PR Newswire JERUSALEM , May 12, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical com...

BiondVax to Present at this week's Biomed Israel Conference PR Newswire JERUSALEM , May 9, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovati...

BiondVax to host a Hebrew-language analyst and investor webinar on April 6th PR Newswire JERUSALEM , April 5, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializi...

BiondVax Pharmaceuticals Ltd. (BVXV) Q4 2021 Earnings Conference Call April 04, 2022 10:00 AM ET Company Participants Kenny Green - Edison Group, IR Josh Phillipson - Director of Business Development and Investor Relations Amir Reichman - Chief Executive Officer Matthias Dobbelstein - Profess...

BiondVax to host analyst and investor webinar on April 4th PR Newswire JERUSALEM , March 31, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative pro...

Clever Leaves Holdings (CLVR) -20% after sharp rally last week. Companhia Energetica (CIG) -15%. BiondVax Pharmaceuticals (BVXV) -9% on FY earnings release. Enservco (ENSV) -8% announces to amend its Financial Statements for First, Second and Third Quarters of 2021. Indone...

Biondvax Pharmaceuticals press release (NASDAQ:BVXV): FY GAAP EPS of -NIS0.07. As of December 31, 2021, cash and cash equivalents of NIS 54 million as compared to NIS 9.4 million as of December 31, 2020. Shares -8.99% PM For further details see: Biondvax Pharmaceuticals G...

BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update PR Newswire JERUSALEM , March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufac...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (NASDAQ: AAPL ) stock is on the move Thursday as investors react to a positive price target for the company’s shares. Source: ZorroGabriel / Shutterstock.com Wedbush analyst Daniel Ives is behind ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BiondVax (NASDAQ: BVXV ) stock is a big mover today, soaring on news of an antibody development agreement. As of this writing, BVXV stock has gained more than 26% as investors price in this catalyst. Source: Shutte...